Miltefosine Plus IL Pentamidine for Bolivian CL

• Status: Completed
• Trial end date: 2018-02-21

Summary

Bolivian cutaneous leishmaniasis due to Leishmania braziliensis was treated with the combination of miltefosine (150 mg/day for 28 days) plus intralesional pentamidine (120 ug/mm2 lesion area on days 1, 3, and 5).

• Phase: Phase 2

Details

• Lead Sponsor: Jonathan Berman
• Treatments: Miltefosine; Pentamidine